Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Revenue

In the year 2023, Kymera Therapeutics had annual revenue of $78.59M with 67.84% growth. Revenue in the quarter ending December 31, 2023 was $47.89M with 196.70% year-over-year growth.

• Revenue (ttm): $78.59M
• Revenue Growth: +67.84%
• P/S Ratio: 26.25
• Revenue / Employee: $420,278
• Employees: 187
• Market Cap: 2.16B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	78.59M	31.77M	67.84%
Dec 31, 2022	46.83M	-26.01M	-35.71%
Dec 31, 2021	72.83M	38.80M	114.00%
Dec 31, 2020	34.03M	31.10M	1,059.99%
Dec 31, 2019	2.93M	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.